Research & Development in
Monthey

BioArk SA

Since 2003 · 11–20 empl.·4.3(21)

Switzerland Global Enterprise supports international companies in their expansion into Switzerland, offering consulting and support in establishing business relationships, finding locations, and navigating the Swiss economy. It is a public support organization that helps companies tap into the Swiss market. In contrast, BioArk provides support and resources for companies in the biotechnology and pharmaceutical industries, particularly in the areas of research and development, production, and distribution. It is a company that offers specialized services and infrastructure for companies in the life sciences sector.

Excellgene SA

Since 2004 · 11–20 empl.·5.0(1)

ExcellGene is a Swiss Biologics-CDMO (Contract Development and Manufacturing Organization) specialized in the development and manufacturing of proteins for the pharmaceutical industry. The company's core activity encompasses providing services for the development and manufacturing of biologics, including: cell line development (CHO and HEK cells), genome engineering, cGMP cell banking, process development, ensuring clonality of existing cell lines, and biosimilars. The company supports pharmaceutical companies in the development and manufacturing of proteins for drug development, offering a combination of scientific expertise and technological infrastructure.

Bionactis International Group (BIG) SA

Since 2009 · 1–10 empl.

Bionactis International Group (BIG) SA conducts adiabatic extraction of active ingredients and provides related technology and research & development services for health applications.

Patrice Ciana, Ciana.ch

Since 2015 · 1–10 empl.

The core activity of the company "Cabinet-Conseil Patrice Ciana" encompasses four main areas: 1. **Corporate Consulting**: The company provides consulting services to support businesses in their development and transformation. 2. **Research Partner**: The company works as a partner for research projects and supports businesses in the development of new products and services. 3. **Product Development**: The company assists businesses in developing new products and services to enhance their innovation capabilities. 4. **Continuing Education**: The company offers customized courses and dialogues to support businesses in the continuing education of their employees. Overall, the core activity of the company can be described as **Digital Transformation and Corporate Consulting**, with a focus on research, product development, and continuing education.

Karmagenes SA

Since 2015 · 1–10 empl.

Karmagenes SA provides business-to-business psychometric and genetic data analyses and insights tailored to partner organizations.

Swiss Biotech Center SA

Since 2016 · 11–20 empl.

The core activity of Swiss Biotech Center is the development and manufacture of biopharmaceutical products, in particular biological medicines, as well as supporting start-ups and companies in the development and marketing of biopharmaceutical products. The company offers services such as research and development, clinical development, manufacturing and marketing of biopharmaceutical products and has an extensive network and expertise in the biotechnology industry.

REM Analytics SA

Since 2020 · 1–10 empl.

The core activity of BioArk SA is the performance of microbiome analyses and food analyses, particularly in the examination of probiotics and their impact on the microbiome. The company offers services such as engraftment tests, quantitative effect analyses and durability analyses to determine the effectiveness of probiotics. Furthermore, BioArk SA provides food analyses, including the identification of origin, variety and pathogens in food. The company aims to support businesses in the development, improvement and certification of products.

Novochizol SA

Since 2021 · 1–10 empl.

The core activity of Novochizol SA is the research and development of technologies for targeted delivery of active pharmaceutical ingredients (APIs) in cells and tissues, particularly in the fields of pharmaceuticals, diagnostics, and medical technology. The company develops products and solutions for various applications, including: * Drug Formulation: Development of formulations for targeted delivery of APIs * Covid-19 In Vitro Diagnostics: Development of diagnostic tools for COVID-19 * Aerosols: Development of aerosol products for various applications * Agrotechnology: Development of solutions for agriculture, including improvement of seed germination and plant growth * Medical Devices: Development of medical devices, including targeted delivery of botulinum toxin for the treatment of atrial fibrillation. The company focuses on developing innovative solutions for various industries and applications, with a focus on targeted delivery of APIs and improvement of diagnostic and therapeutic methods.

Catexel Production Switzerland GmbH

Since 2025 · 21–50 empl.

Catexel Production Switzerland GmbH develops and produces specialty chemicals for applications in home care, industrial and institutional cleaning, personal care, and other markets. Its portfolio includes bleach activators, bleach catalysts, surfactants, hydrotropes, emulsifiers, polymers, and builders.

Swissaustral Biotech SA

Since 2009 · 1–10 empl.

Target Advisory Sàrl

Since 2024 · 1–10 empl.

Earthshot Labswork SA

Since 2025 · 1–10 empl.